2009
DOI: 10.1017/s0033291709990286
|View full text |Cite
|
Sign up to set email alerts
|

The psychoses: Cluster 3 of the proposed meta-structure for DSM-V and ICD-11

Abstract: Carpenter, W. T. Jr.; Bustillo, J. R.; Thaker, G. K.; van Os, J.; Krueger, R. F.; and Green, M. J., ,"The psychoses: Cluster 3 of the proposed meta-structure for DSM-V and ICD-11." Psychological Medicine.39,12. 2025-2042 The psychoses: Cluster 3 of the proposed meta-structure for DSM-V and ICD-11 Background. In an effort to group mental disorders on the basis of etiology, five clusters have been proposed. Here we consider the validity of the cluster comprising selected psychotic and related disorders.Method. A… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

10
81
0
2

Year Published

2010
2010
2018
2018

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 83 publications
(93 citation statements)
references
References 221 publications
(257 reference statements)
10
81
0
2
Order By: Relevance
“…87 Our findings therefore provide further support for a reappraisal of these disorders as distinct diagnostic entities, 32 although other evidence for the distinct character must also be considered in any such reappraisal. 32,49,88,89 In keeping with previous proteomic studies of schizophrenia and bipolar disorder, 38 including one of the hippocampus in schizophrenia, 90 our findings implicate proteins involved in cytoskeletal 42,46,90 and metabolic 42,45,46,48,58 cellular mechanisms and, specifically in bipolar disorder, cell death pathways. 91,92 The results complement findings of transcriptomic investigations in these brain regions.…”
Section: Commentsupporting
confidence: 88%
“…87 Our findings therefore provide further support for a reappraisal of these disorders as distinct diagnostic entities, 32 although other evidence for the distinct character must also be considered in any such reappraisal. 32,49,88,89 In keeping with previous proteomic studies of schizophrenia and bipolar disorder, 38 including one of the hippocampus in schizophrenia, 90 our findings implicate proteins involved in cytoskeletal 42,46,90 and metabolic 42,45,46,48,58 cellular mechanisms and, specifically in bipolar disorder, cell death pathways. 91,92 The results complement findings of transcriptomic investigations in these brain regions.…”
Section: Commentsupporting
confidence: 88%
“…This meta-structure project examined internalizing/emotional (consisting of DSM-IV anxiety, depressive and somatoform disorders, and neurasthenia), disinhibited externalizing (conduct, antisocial personality, and substancerelated disorders), thought disorder/psychotic (schizophrenia spectrum disorders, schizotypal PD, and bipolar I disorder), neurocognitive (delirium, dementias, amnestic and other cognitive disorders), and neurodevelopmental (learning, motor skills and communication disorders, pervasive developmental disorders, and mental retardation) spectra. Overall, data for validators included in the reviews generally supported the coherence of these five spectra (Andrews, Pine et al, 2009;Carpenter et al, 2009;Goldberg, Krueger, Andrews, & Hobbs, 2009;Krueger & South, 2009;Sachdev et al, 2009), and more recent reviews have continued to support these conclusions (Beauchaine & McNulty, 2013;Eaton, Rodriguez-Seijas, Carragher, & Krueger, 2015;Nelson et al, 2013).…”
Section: Validation Of Spectramentioning
confidence: 82%
“…This work informs our understanding of phenotypes and the mission to improve diagnostic validity. For example, a proposed test of the validity of mental disorder diagnosis for DSM-V includes identified genetic risk factors (Carpenter et al, 2009). If biological or genetic factors are an important test of the validity of mental disorder diagnosis, this evidence suggests the importance of measuring smoking heaviness and "Craving" to reflect part of the underlying genetic risk.…”
Section: Discussionmentioning
confidence: 99%